Blue Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Blue Trust's ARKG Position: Q3 2026 in Review
Blue Trust opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2026: 26 shares worth $1.39K. The stake represents ﹤0.01% of the portfolio and ranks #2112 among its holdings. This is a return to the name: Blue Trust previously reported a position in ARKG as recently as Q3 2025.
Blue Trust first reported a position in ARKG in Q2 2022 and has held it in 12 quarters since. The position peaked at $22K in Q2 2022. 268 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- Blue Trust held 26 shares of ARK Genomic Revolution ETF worth $1.39K as of Q3 2026.
- ARK Genomic Revolution ETF was a new Blue Trust position in Q3 2026.
- ARK Genomic Revolution ETF made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2112 holding.
- Blue Trust first reported a position in ARK Genomic Revolution ETF in Q2 2022 and has held it in 12 quarters since.
- Blue Trust's ARK Genomic Revolution ETF position peaked at $22K in Q2 2022.
- 268 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.